05/29/2026
Coronary microvascular dysfunction (CMD) puts patients at greater risk for death, heart attack, repeat revascularization and heart failure (HF) hospitalization, and patients with or without epicardial coronary artery disease (CAD) should be evaluated for CMD, according to data from a new registry analysis. Read more from EuroPCR 2026 on CRTonline.
Coronary microvascular dysfunction (CMD) puts patients at greater risk for death, heart attack, repeat revascularization and heart failure (HF) hospitalization, and patients with or without epicardial